PXS Provexis plc

0.0093USD0.7050 GBp · LSE-17.54%Mkt Cap: 21.78M USDP/E: —

Provexis plc, together with its subsidiaries, develops, licenses, and sells functional foods, medical foods, and dietary supplements worldwide. It provides syrup and powder versions of Fruitflow, a tomato extract that re…

Key Statistics

Company
Market Cap21.78M USD
Enterprise Value24.53M USD
Revenue (TTM)1.67M USD
Gross Profit672.77K USD
Net Income (TTM)-662.06K USD
Revenue/Share0.0013 USD
Last Price0.0093 USD
Fiscal Year EndMar 2026
MR QuarterMar 2026
Employees2
CountryGB
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINGB00B0923P27
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue14.73
P/S13.08
P/B—
EPS (TTM)0.00 USD
EPS (Forward)—
52W Range
0.007315% of range0.0204
52W High0.0204 USD
52W Low0.0073 USD
Profitability
Gross Margin40.40%
Oper. Margin-40.45%
EBITDA Margin0.00%
Profit Margin-39.76%
ROE-45.46%
ROA-38.82%
ROIC—
ROCE-89.39%
Growth
Revenue Growth77.60%
Earnings Growth—
Cash Flow & Leverage
Operating CF236.83K USD
CapEx (TTM)—
FCF Margin28.90%
FCF Yield2.21%
Net Debt-1.18M USD
Net Debt/EBITDA—
Net Debt/FCF-2.44
Balance Sheet
Debt/Equity—
Current Ratio1.79
Quick Ratio1.37
Book Value/Sh0.00 USD
Cash/Share0.00 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split2:1
Split DateJun 23, 2005
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.2.35B
Float1.82B
Insiders21.11%
Institutions9.87%
Technical
SMA 500.0124 (-25.2%)
SMA 2000.0142 (-34.8%)
Beta0.68
S&P 52W Chg12.08%
Avg Vol (30d)841.94K
Avg Vol (10d)373.26K
Technical Indicators
RSI (14)31.6
MACD-0.0387
MACD Signal-0.0336
MACD Hist.-0.0051
BB Upper0.0128 USD
BB Middle0.0113 USD
BB Lower0.0098 USD
BB Width26.81%
ATR (14)0.0024 USD
Vol Ratio (20d)34.52x

About Provexis (LON: PXS)

›

Provexis (LON: PXS) is listed on the London Stock Exchange, where its shares trade in pence sterling (GBp). It belongs to the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector, and reports about 2 employees.

The shares were at 0.7050 GBp on 19 November 2026, up 23.7% over 52 weeks. Its 52-week range is 0.5550 GBp to 1.550 GBp: the price is 54.5% below the high and 27.0% above the low.

Its market capitalisation is 16.54M GBP.

Provexis reports return on equity of -45.5%, an operating margin of -40.5% and revenue up 77.6% year over year.

It holds more cash than debt, a net cash position of 893.14K GBP. Its Piotroski F-score is 4 out of 9, an average reading of its financial health.